Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by Penn State University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Penn State University
ClinicalTrials.gov Identifier:
NCT00284960
First received: January 31, 2006
Last updated: NA
Last verified: June 2005
History: No changes posted

January 31, 2006
January 31, 2006
July 2005
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
The Incidence and Treatment of Insulin Resistance Among Men With Erectile

Determine if men with erectile dysfunction (ED) are more likely to have insulin resistance compared to healthy controls.

Insulin is a hormone produced by the body that lets sugar into the cells, where it is used for energy. Insulin resistance occurs when the body’s cells have a decreased ability to react to insulin. This leads to an increase in insulin secretion. Over time, insulin resistance can lead to higher levels of sugar in the blood (diabetes), and can also contribute to obesity, high blood pressure, high cholesterol levels and heart disease. There are no simple tests to actually diagnose insulin resistance. Currently, the glucose tolerance test is used to diagnose IR, but it involves several blood draws over a 2-hour period. Another purpose of this study is to compare a blood test involving only one blood draw to the 2-hour glucose tolerance test, which involves several blood draws over a 2-hour period.

It is well known that diabetes often leads to erectile dysfunction. Because insulin resistance occurs before diabetes, it is possible that erectile dysfunction may occur in some individuals while they have insulin resistance, but before they develop diabetes. If this is true, it might be possible to use erectile dysfunction as a sign of insulin resistance, which may lead to more timely treatment of insulin resistance and may delay or prevent the development of diabetes, and the other problems mentioned above.

Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Not Provided
Not Provided
  • Erectile Dysfunction
  • Metabolic Syndrome
  • Insulin Resistance
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
June 2006
Not Provided

Inclusion Criteria:

  • 18-65 years of age, male,

Exclusion Criteria:

  • diabetes, peyronies
Male
18 Years to 65 Years
Yes
Contact: Sue Worley, RN 717-531-5718 sworley@psu.edu
United States
 
NCT00284960
18805, NIH: K24 H001476
Not Provided
Not Provided
Penn State University
Not Provided
Principal Investigator: J C Trussell, MD
Penn State University
June 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP